GlassScriptPhysician profile
Ang Li
NPI 1386088268
$7,544.64
in general payments reported to CMS, 2019-2025
47 companies · $1,249 in 2025
The $1,249 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $880 · 2020: $864 · 2021: $1,359 · 2022: $961 · 2023: $1,243 · 2024: $988 · 2025: $1,249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,382 · Education: $98.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,382.03 |
| Education | $98.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,163.01 | 2021-2025 | |
| Harmony Biosciences LLC | $568.80 | 2020-2025 | Wakix |
| Allergan, INC. | $527.08 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $417.67 | 2020-2021 | |
| Argenx US, INC. | $370.79 | 2023-2025 | Vyvgart Hytrulo, Vyvgart |
| Lilly USA, LLC | $354.35 | 2019-2025 | Emgality, Zepbound, Mounjaro |
| Amgen INC. | $323.43 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $294.47 | 2021-2025 | Austedo Xr, Austedo Xr |
| Pfizer INC. | $274.18 | 2023-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $211.71 | 2022 | |
| Axsome Therapeutics, INC. | $192.56 | 2023-2025 | Sunosi, Symbravo |
| Jazz Pharmaceuticals INC. | $161.89 | 2022-2025 | |
| Tanabe Pharma America, INC. | $131.71 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $114.17 | 2019-2025 | |
| Scilex Pharmaceuticals INC. | $112.85 | 2023-2024 | Ztlido |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ang Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.